Does metformin cause loose stools
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Metformin and Its Impact on Gastrointestinal Health: Loose Stools
Introduction to Metformin and Gastrointestinal Side Effects
Metformin is a widely prescribed medication for managing Type 2 diabetes mellitus (T2DM). Despite its efficacy in controlling blood glucose levels, it is often associated with gastrointestinal (GI) side effects, which can limit its use and patient adherence. One of the common GI symptoms reported by patients on metformin is loose stools.
Mechanism of Metformin-Induced Loose Stools
Bile Salt Malabsorption and Intestinal Motility
Research has shown that metformin can alter bile salt circulation and intestinal motility, which may contribute to loose stools. A study investigated the effects of metformin on oral-caecal transit time and bile salt absorption. The findings indicated that while metformin did not significantly change the oral-caecal transit time, it did increase the percentage of bile salts excreted in the stool. This increase in bile salt excretion was significantly associated with the liquidity of the stool, suggesting that metformin may cause loose stools by reducing ileal bile salt reabsorption, leading to elevated colonic bile salt concentrations.
Microbiota Composition and Activity
Another study explored the effects of metformin on the gut microbiota and its potential role in GI symptoms. The study found that metformin could cause shifts in the microbiota composition, particularly increasing the presence of Proteobacteria, Enterobacteriaceae, and Enterobacteriales. These changes in the gut microbiome were associated with GI symptoms, including changes in stool frequency and form. Although the study did not find significant differences in stool frequency or composition between the metformin and placebo groups, the distinct shifts in microbiome signatures suggest a potential link between metformin-induced microbiota changes and GI symptoms.
Conclusion
In summary, metformin can cause loose stools primarily through mechanisms involving bile salt malabsorption and alterations in gut microbiota composition. These findings highlight the importance of monitoring GI symptoms in patients on metformin and exploring adjunctive therapies, such as prebiotics, to mitigate these side effects. Understanding these mechanisms can help improve patient adherence and optimize the therapeutic efficacy of metformin in managing Type 2 diabetes mellitus.
Sources and full results
Most relevant research papers on this topic